
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients
Esposito, S., Meregalli, E., Daleno, C., Ghio, L., Tagliabue, C., Valzano, A., Serra, D., Galeone, C., Edefonti, A., Principi, N.Volume:
26
Langue:
english
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfq657
Date:
June, 2011
Fichier:
PDF, 97 KB
english, 2011